EUCTR2012-005520-15-FR进行中（未招募）不适用
Phase III study comparing maintenance by pemetrexed or gemcitabine to surveillance in elderly patient (= 70 year old) with advanced Non Small Cell Lung Cancer controlled by induction chemotherapy - MODE
IFCT0 个研究点开始时间: 2013年4月9日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Histologically or cytologically documented Non Small Cell Lung Cancer
- •non resecable or non irradiable stage III or stage IV
- •EGFR wild type or non feasible EGFR
- •89 >Age = 70
- •ECOG Performance status : 0, 1 or 2
- •Mini-Mental Test Status (MMS) > 23
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 546
排除标准
- •Mixed non-small cell and small cell tumors
- •Patients with EGFR mutated tumor
- •Patient with EML4-ALK translocation
- •Evolutive or symptomatic metastasis of central nervous system
- •Superior vena cava syndrome
- •Calcemia > 2,70 mmol/L
研究者
相似试验
已完成
不适用
Phase II study of pemetrexed maintenance with or without bevacizumab after a first line treatment chemotherapy with bevacizumab-carboplatin-pemetrexed in patients with advanced, metastatic or recurrent non-squamous non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000010002Internal Medicine 2, Hamamatsu University School of Medicine.110
已完成
不适用
A randomized phase 2 study of maintenance pemetrexed versus docetaxel following pemetrexed plus carboplatin in advanced non-small cell lung cancerJPRN-UMIN000004075Hamamatsu University School of Medicine84
招募中
不适用
Randomized phase II study of maintenance pemetrexed, bevacizumab, and pemetrexed+bevacizumab after induction chemotherapy with carboplatin+pemetrexed in advanced nonsquamous NSCLC.nonsquamous NSCLCJPRN-UMIN000006620Kyoto Thoracic Oncology Research Group99
Unknown
3 期
Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based ChemotherapyUreter CancerTransitional Cell CarcinomaBladder CancerNCT03193788Asan Medical Center74
进行中（未招募）
不适用
A Phase 3 Study of Pemetrexed Plus Best Supportive Care versus Best Supportive Care As Maintenance Therapy Immediately Following Induction Treatment For Advanced Non-Small Cell Lung CancerEUCTR2004-002425-52-ESilly S.A.660